Apotex Launches Apparent First Abraxane Generic – With Little Fanfare

Teva Was Cleared To Launch From 31 March Under Settlement Agreement

 
• By Dean Rudge

Apotex has confirmed launch of a generic version of Bristol Myers Squibb’s Abraxane, with details thin on the ground.

Apotex
Apotex is not listed among ANDA approvals for Abraxane • Source: Shutterstock

More from Products

More from Generics Bulletin